Description
CJC-1295 is a synthetic research peptide studied in laboratory models involving growth hormone-releasing hormone receptor pathways and peptide signaling.
This product is intended for qualified research use only. It is not intended for human or animal consumption, medical use, diagnosis, treatment, or prevention of disease.
A growth-hormone releasing hormone analog commonly reviewed for GH pulse support.
Product focus: Clinician-guided protocol item
Review focus
- GH
- Recovery
Research context
- Extends growth-hormone releasing hormone signaling depending on form.
- Often paired with a GHRP such as ipamorelin.
Review before use
- Review IGF-1, glucose, sleep apnea risk, cancer history, and edema symptoms.
- Clarify DAC versus no-DAC form before any protocol discussion.
Cautions
- Hormone-pathway agents need lab monitoring.
- Avoid if contraindicated by personal cancer risk or unmanaged metabolic disease.
Research use only. This product is sold for laboratory research use only and is not for human or animal consumption. This description is educational context and is not medical advice, dosing guidance, or a treatment claim.

Reviews
There are no reviews yet.